Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Mechanisms of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07359040
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:14.260112+00:00
Published At
2026-03-12T00:00:00+00:00
Record Updated At
2026-03-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Non-Small Cell Lung Cancer", "Neoadjuvant Therapy", "PD-1 Inhibitors", "Immunotherapy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-12"
protocolSection.identificationModule.nctId
"NCT07359040"
protocolSection.identificationModule.officialTitle
"Mechanisms of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Neoadjuvant Therapy (protocolSection.conditionsModule.conditions)
  • PD-1 Inhibitors (protocolSection.conditionsModule.conditions)
  • Immunotherapy (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.